Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Organic Revenue Growth — Specialty Diagnostics by Year
Organic Revenue Growth — Specialty Diagnostics (%)
Thermo Fisher Scientific Organic Revenue Growth — Specialty Diagnostics: 2.0% in FY2025, down 1.0 pts from a year earlier.
Where the FY2025 figure comes from
“SD: Organic revenue growth (non-GAAP measure) 4% 0% 2% 3% 2% -3% 5% 0%”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package (Business Segment Information) & SEC MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Organic Revenue Growth — Specialty Diagnostics (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.0% | -1.0 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 3.0% | +16.0 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | -13.0% | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Breakdown
What makes up organic Revenue Growth — Specialty Diagnostics
Cite this data
StockData. (2026). Thermo Fisher Scientific Organic Revenue Growth — Specialty Diagnostics (%), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-growth-pct-sd
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.